Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Compartment Models: Single-Compartment Model01:14

Compartment Models: Single-Compartment Model

3.5K
The single-compartment model serves as a simplified representation of the human body. This model assumes that the body functions as a single, well-mixed open compartment. When a drug is administered intravenously, it enters the body and quickly distributes uniformly. The drug then undergoes biotransformation and elimination, ultimately leaving the body. The volume of this compartment is referred to as the apparent volume of distribution into which the drug can uniformly distribute. In this...
3.5K
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

7.4K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
7.4K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

654
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
654
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

843
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
843
Three-Compartment Open Model01:06

Three-Compartment Open Model

1.0K
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
1.0K
Two-Compartment Open Model: Extravascular Administration01:12

Two-Compartment Open Model: Extravascular Administration

761
The two-compartment model for extravascular administration represents a drug's absorption and distribution process. It features a central compartment, where the drug is first absorbed, and a peripheral compartment, which illustrates the drug's distribution throughout the body. The rate of change in drug concentration in the central compartment is calculated by three exponents: absorption, distribution, and elimination.
The absorption exponent (ka) indicates the speed at which the drug...
761

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ectopic Intratracheal Thyroid Tissue Leading to Stridor.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India·2019
Same author

A Comparative Evaluation of Removal of Intracanal Calcium Hydroxide with Endoactivator System and Mechanical Instrumentation with K File, Using Two Irrigating Solutions: an in Vitro Study.

Kathmandu University medical journal (KUMJ)·2019
Same author

Gamma and Beta Absorbed Dose Conversion Coefficients in the Range from 10 keV to 10 MeV for Accidental Exposures From Point Sources Placed in Clothing in Proximity to the Body.

Health physics·2018
Same author

Evaluation of Reference Urinary Excretion Concentrations of Selected Radionuclides Corresponding to Clinical Decision Guides for Application in Radiological and in Nuclear Emergencies.

Radiation protection dosimetry·2016
Same author

Efficacy of Prussian blue on 137Cs decorporation therapy.

Health physics·2014
Same author

Idiopathic pulmonary haemosiderosis in a child with Down's syndrome: case report and review of the literature.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2013

Related Experiment Video

Updated: Mar 1, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.5K

A BRIEF OVERVIEW OF COMPARTMENTAL MODELING FOR INTAKE OF PLUTONIUM VIA WOUNDS.

D Poudel1, J A Klumpp1, T L Waters1

  • 1Radiation Protection Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.

Radiation Protection Dosimetry
|June 8, 2017
PubMed
Summary

This study reviews models for radioactive material behavior in wounds, focusing on plutonium. It highlights challenges in modeling unperturbed wound exposures and recommends using human data to refine existing biokinetic models.

More Related Videos

Speciation and Bioavailability Measurements of Environmental Plutonium Using Diffusion in Thin Films
12:22

Speciation and Bioavailability Measurements of Environmental Plutonium Using Diffusion in Thin Films

Published on: November 9, 2015

11.9K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.4K

Related Experiment Videos

Last Updated: Mar 1, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.5K
Speciation and Bioavailability Measurements of Environmental Plutonium Using Diffusion in Thin Films
12:22

Speciation and Bioavailability Measurements of Environmental Plutonium Using Diffusion in Thin Films

Published on: November 9, 2015

11.9K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.4K

Area of Science:

  • Radiological Health Physics
  • Biokinetics
  • Contaminant Transport

Background:

  • Modeling radioactive material behavior in contaminated wounds is complex due to variable wound characteristics and limited human data for unperturbed exposures.
  • Existing biokinetic models, such as the National Council on Radiation Protection and Measurements (NCRP) 156 model, are often based on animal data.
  • Medical interventions like excision or chelation in documented human cases limit the availability of data for unperturbed wound scenarios.

Purpose of the Study:

  • To present various approaches for modeling radioactive material (specifically plutonium) behavior in contaminated wounds.
  • To review validation and revision efforts of the NCRP 156 biokinetic wound model by the health physics community.
  • To provide general recommendations for improving wound biokinetic models.

Main Methods:

  • Literature review of existing biokinetic models for radioactive material wound contamination.
  • Analysis of challenges in modeling wound characteristics (solubility, chemistry, tissue injury, location).
  • Evaluation of data limitations for unperturbed human wound exposures.

Main Results:

  • Several modeling approaches for radioactive material in wounds have been identified.
  • Significant challenges exist in developing accurate biokinetic models due to wound complexity and data scarcity.
  • Current models, like NCRP 156, require further validation and refinement using human data.

Conclusions:

  • Accurate modeling of radioactive material behavior in wounds necessitates addressing numerous complex factors.
  • There is a critical need to validate and improve biokinetic models using human data, especially for unperturbed exposures.
  • Continued research and data collection from human cases are essential for enhancing radiation protection standards for wound contamination.